Gemcitabine in Treating Children With Refractory Solid Tumors

Completed · Phase 1

Conditions studied: Unspecified Childhood Solid Tumor, Protocol Specific

In brief

Phase I trial to study the effectiveness of gemcitabine in treating children who have refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Key facts

Study ID

NCT00005577

Run by

National Cancer Institute (NCI)

People needed

30

Starts

1996-08-01

Last updated by the study team

2013-02-05

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Children's Hospital Los Angeles — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Cancer Center and Beckman Research Institute, City of Hope — Los Angeles, California, United States
• Children's Hospital of Orange County — Orange, California, United States
• UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
• Children's National Medical Center — Washington D.C., District of Columbia, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• Children's Mercy Hospital — Kansas City, Missouri, United States
• NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Herbert Irving Comprehensive Cancer Center — New York, New York, United States
• Children's Hospital Medical Center - Cincinnati — Cincinnati, Ohio, United States
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
• Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
• Huntsman Cancer Institute — Salt Lake City, Utah, United States
• Children's Hospital and Regional Medical Center - Seattle — Seattle, Washington, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States
• Princess Margaret Hospital for Children — Perth, Western Australia, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.